CSPAX
Price
$72.64
Change
-$0.18 (-0.25%)
Updated
Aug 15 closing price
Net Assets
80.31B
LLGLX
Price
$14.70
Change
+$0.02 (+0.14%)
Updated
Aug 15 closing price
Net Assets
259.22M
Interact to see
Advertisement

CSPAX vs LLGLX

Header iconCSPAX vs LLGLX Comparison
Open Charts CSPAX vs LLGLXBanner chart's image
American Funds SMALLCAP World 529A
Price$72.64
Change-$0.18 (-0.25%)
VolumeN/A
Net Assets80.31B
Longleaf Partners Global
Price$14.70
Change+$0.02 (+0.14%)
VolumeN/A
Net Assets259.22M
CSPAX vs LLGLX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
CSPAX vs. LLGLX commentary
Aug 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSPAX is a Buy and LLGLX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CSPAX has more cash in the bank: 80.3B vs. LLGLX (259M). LLGLX pays higher dividends than CSPAX: LLGLX (2.92) vs CSPAX (0.58). CSPAX was incepted earlier than LLGLX: CSPAX (24 years) vs LLGLX (13 years). LLGLX (1.29) is less costly to investors than CSPAX (1.06). LLGLX is a more actively managed with annual turnover of: 62.00 vs. CSPAX (32.00). CSPAX has a lower initial minimum investment than LLGLX: CSPAX (250) vs LLGLX (10000). LLGLX annual gain was more profitable for investors over the last year : 14.18 vs. CSPAX (10.22). LLGLX return over 5 years is better than : 26.21 vs. CSPAX (14.95).
CSPAXLLGLXCSPAX / LLGLX
Total Expense Ratio1.061.05101%
Annual Report Gross Expense Ratio1.061.2982%
Fund Existence24 years13 years-
Gain YTD9.65011.78782%
Front Load4%N/A-
Min. Initial Investment250100003%
Min. Initial Investment IRAN/AN/A-
Net Assets80.3B259M31,004%
Annual Yield % from dividends0.582.9220%
Returns for 1 year10.2214.1872%
Returns for 3 years21.6032.1267%
Returns for 5 years14.9526.2157%
Returns for 10 years50.8248.27105%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FPHAX24.890.35
+1.43%
Fidelity Select Pharmaceuticals Port
ETCEX12.80N/A
N/A
Eventide Exponential Technologies C
QILGX41.30N/A
N/A
Federated Hermes MDT Large Cap Growth IS
OIEIX25.09-0.07
-0.28%
JPMorgan Equity Income A
LSRCX1.85-0.02
-1.07%
Lord Abbett Small Cap Value C